CRN Criticizes FDA’s ‘Nonresponsive’ Response to Citizen Petition on NAC
CRN responded today to FDA’s November 2021 decision not to address CRN’s citizen petition regarding N-acetyl-L-cysteine (NAC) on a timely basis, calling on the agency for swift review of the legal questions CRN raised.
